UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.6% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
8301
Principal International Equity ETF
PIEQ
$1.35B
| $13.1K | ﹤0.01% |
+366
| New | +$12.9K |
2026 Q2
0 quarters
|
|
8302
REX-Osprey XRP ETF
XRPR
$41.8M
| $13.1K | ﹤0.01% |
+1,531
| New | +$16.4K |
2026 Q2
0 quarters
|
|
8303
FT U.S. Equity Max Buffer ETF - January
JANM
$37.1M
| $13.1K | ﹤0.01% |
388
+378
| +3,780% | +$12.7K |
2025 Q4
2 quarters
|
|
8304
VistaGen Therapeutics
VTGN
$8.18M
| $13.1K | ﹤0.01% |
57,830
-20,906
| -27% | -$12.6K |
2022 Q4
14 quarters
|
|
8305
Polen International Dividend Income Fund
IDVZ
$203M
| $13.1K | ﹤0.01% |
+380
| New | +$13.2K |
2026 Q2
0 quarters
|
|
8306
EON Resources
EONR
$14.4M
| $13K | ﹤0.01% |
29,512
-427,468
| -94% | -$284K |
2024 Q1
9 quarters
|
|
8307
SOAR AI, Inc.
SOAR
$11.7M
| $13K | ﹤0.01% |
80,458
-722
| -0.9% | -$154 |
2024 Q4
6 quarters
|
|
8308
DELISTED
REE Automotive
REE
| $13K | ﹤0.01% |
66,501
+62,798
| +1,696% | +$28.6K |
2022 Q3
15 quarters
|
|
8309
Algorhythm Holdings
RIME
$1.82M
| $13K | ﹤0.01% |
22,745
-43,505
| -66% | -$36.4K |
2025 Q1
5 quarters
|
|
8310
22nd Century Group
XXII
$898K
| $13K | ﹤0.01% |
55
+51
| +1,275% | +$59.5K |
2014 Q4
46 quarters
|
|
8311
Northern Trust Intermediate Tax-Exempt Bond ETF
TAXI
$166M
| $12.9K | ﹤0.01% |
+252
| New | +$12.9K |
2026 Q2
0 quarters
|
|
8312
Crossmark Large Cap Growth ETF
CLCG
$26.8M
| $12.9K | ﹤0.01% |
+447
| New | +$12.5K |
2026 Q2
0 quarters
|
|
8313
Braiin Ltd
BRAI
$414M
| $12.9K | ﹤0.01% |
2,114
-268
| -11% | -$2.06K |
2026 Q1
1 quarter
|
|
8314
STF Tactical Growth & Income ETF
SEPQ
$91.2M
| $12.9K | ﹤0.01% |
455
+387
| +569% | +$10.4K |
2026 Q1
1 quarter
|
|
8315
WBI Power Factor High Dividend ETF
WBIY
$63.2M
| $12.9K | ﹤0.01% |
369
-221
| -37% | -$7.61K |
2025 Q1
5 quarters
|
|
8316
FT Vest Bitcoin Strategy & Target Income ETF
DFII
$18.9M
| $12.9K | ﹤0.01% |
+1,159
| New | +$15.8K |
2026 Q2
0 quarters
|
|
8317
Lakewood-Amedex Biotherapeutics
LABT
$991K
| $12.9K | ﹤0.01% |
+4,098
| New | +$70.3K |
2026 Q2
0 quarters
|
|
8318
Avantis International Large Cap Value ETF
AVIV
$2.09B
| $12.9K | ﹤0.01% |
166
-131
| -44% | -$10.2K |
2024 Q3
7 quarters
|
|
8319
Bloomia Holdings
TULP
$11.2M
| $12.8K | ﹤0.01% |
3,576
+3
| +0.1% | +$12 |
2023 Q2
12 quarters
|
|
8320
Teamshares Inc
TMS
$380M
| $12.8K | ﹤0.01% |
+1,556
| New | +$15.7K |
2026 Q2
0 quarters
|
|
8321
New Providence Acquisition Corp III Units
NPACU
| $12.8K | ﹤0.01% |
1,224
-1,136
| -48% | -$11.8K |
2025 Q2
4 quarters
|
|
8322
Rafael Holdings
RFL
$56.4M
| $12.8K | ﹤0.01% |
3,891
+1,954
| +101% | +$3.14K |
2018 Q1
33 quarters
|
|
8323
Lifetime Brands
LCUT
$172M
| $12.7K | ﹤0.01% |
1,491
-41,195
| -97% | -$319K |
2021 Q3
19 quarters
|
|
8324
FT Vest Emerging Markets Buffer ETF - March
TMAR
$17.7M
| $12.7K | ﹤0.01% |
+487
| New | +$12.4K |
2026 Q2
0 quarters
|
|
8325
YieldMax Ultra Option Income Strategy ETF
ULTY
$557M
| $12.7K | ﹤0.01% |
428
-11,108
| -96% | -$345K |
2025 Q2
4 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,282 new, 4,216 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,282 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.